Artificial intelligence (AI) has dramatically expanded the toolkit available for reverse engineering, and in-house counsel might wish to take note.
Continue Reading Reverse Engineering in the Age of AI: Are Your Trade Secrets Still Safe?
Drawing the Lines: Intellectual Property in AI Ecosystems
AI’s ability to teach itself borders on metaphysical, so harnessing the benefits of this phenomenon — by both providers and customers — requires thoughtful navigation.
Typically, a provider offers its proprietary
Continue Reading Drawing the Lines: Intellectual Property in AI Ecosystems
New York Poised to Be at the Forefront of AI Regulation; Five Bills Await Gov. Hochul’s Action
Among the hundreds of bills passed during New York’s 2025 legislative session are several pieces of legislation that impose regulations on developing and using AI. While some of the measures
Continue Reading New York Poised to Be at the Forefront of AI Regulation; Five Bills Await Gov. Hochul’s Action
Data Center Development and the Rise of SLA Insurance
Data center development is booming—driven by AI and other high-throughput workloads. But beyond the physical buildout, a new product is emerging that might enhance the sector’s value proposition: SLA insurance.
The
Continue Reading Data Center Development and the Rise of SLA Insurance
Executive Order Aims to Accelerate Commercial Space Development Through Deregulation
On August 13, 2025, President Trump signed Executive Order 14335, “Enabling Competition in the Commercial Space Industry,” marking a significant step toward accelerating U.S. space launches and activities. The order prioritizes national competitiveness, mandates faster licensing and permitting, and assigns clear responsibilities to federal agencies to support commercial space growth through 2030.
Continue Reading Executive Order Aims to Accelerate Commercial Space Development Through Deregulation
Decoding Proposed Rule 707: A New Gatekeeper for Expert Testimony?
On June 10, 2025, the U.S. Courts’ Committee on Rules of Practice and Procedure approved a set of proposed amendments to the Federal Rules, including introducing Proposed Federal Rule of
Continue Reading Decoding Proposed Rule 707: A New Gatekeeper for Expert Testimony?
How Robotics Startups Can Avoid Costly IP Mistakes
Robotics startups can live or die by their intellectual property (IP). Strong IP can protect innovations, deter competitors, and be the difference between attracting investment or being left behind.
Continue Reading How Robotics Startups Can Avoid Costly IP Mistakes
AI Antitrust Landscape 2025: Federal Policy, Algorithm Cases, and Regulatory Scrutiny
As AI adoption accelerates, government regulators and private plaintiffs are closely examining its impact on competition. In July 2025, the White House released America’s AI Action Plan, emphasizing innovation and regulatory relief, while class action lawsuits and enforcement actions highlight growing risks around algorithmic pricing and data control. This GT Advisory unpacks key developments and offers practical compliance tips for businesses navigating AI-related antitrust issues.
Continue Reading AI Antitrust Landscape 2025: Federal Policy, Algorithm Cases, and Regulatory Scrutiny
Action Required for Manufacturers of Connected Devices: Challenges Under the EU Data Act
The upcoming EU Data Act introduces a user-centric approach to data generated by IoT devices, giving individuals and organizations unprecedented control over both personal and non-personal data. Discover what this paradigm shift means for data holders, business models, and the future of data sharing in the EU.
Continue Reading Action Required for Manufacturers of Connected Devices: Challenges Under the EU Data Act
Japan’s AMED Offers ‘Double Match Up’ Grants for Pharma Startups: Considerations for Investors and Companies
The Japanese government is aware of the challenges in securing funds for drug development within Japan’s biopharmaceutical startup ecosystem, especially compared to Europe and the United States. The Japan Agency for Medical Research and Development has established a program to support biopharmaceutical startups involved in developing patentable pharmaceuticals and regenerative medicine products and therapeutics.
Continue Reading Japan’s AMED Offers ‘Double Match Up’ Grants for Pharma Startups: Considerations for Investors and Companies